NCT06944106 A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT06941857 NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT06938906 Multimodal Therapy Impact on Pancreatic Cancer Survival Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06938282 An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06937112 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis Status RECRUITING Phase N/A
NCT06920082 Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT06898385 A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation Status RECRUITING Phase PHASE1
NCT06893276 e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients Status NOT_YET_RECRUITING Phase NA
NCT06885424 A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products Status ENROLLING_BY_INVITATION Phase N/A
NCT06873178 The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06872489 Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors Status AVAILABLE Phase N/A
NCT06866977 A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06849063 Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE Status RECRUITING Phase N/A
NCT06844422 Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) Status RECRUITING Phase PHASE1/PHASE2
NCT06843629 Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors Status RECRUITING Phase N/A
NCT06821048 Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors Status RECRUITING Phase PHASE1